Healthcare - Medical - Diagnostics & Research - NYSE - US
$ 192.68
-5.06 %
$ 35 B
Market Cap
26.36
P/E
CASH FLOW STATEMENT
2.15 B
OPERATING CASH FLOW
-1.6 B
INVESTING CASH FLOW
-382 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
IQVIA Holdings Inc.
| Net Income | 1.36 B |
| Depreciation & Amortization | 1.12 B |
| Capital Expenditures | -649 M |
| Stock-Based Compensation | 217 M |
| Change in Working Capital | -280 M |
| Others | -161 M |
| Free Cash Flow | 1.5 B |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||
| Net Income | 1 358.0 | 1 091.0 | 971.0 | 308.0 | 227.0 | 284.0 | 1 328.0 | 130.0 | 388.3 | 356.5 | 226.0 | 176.6 | 240.3 | 165.3 |
| Depreciation & Amortization | 1 125.0 | 1 130.0 | 1 264.0 | 1 287.0 | 1 202.0 | 1 141.0 | 1 011.0 | 289.0 | 127.7 | 121.0 | 107.5 | 98.3 | 92.0 | 84.2 |
| Deferred Income Tax | (269.0) | (115.0) | (138.0) | (176.0) | (157.0) | (177.0) | (1 216.0) | 135.0 | 18.4 | (6.2) | (24.2) | 16.6 | (73.2) | (9.0) |
| Stock Based Compensation | 217.0 | 194.0 | 170.0 | 95.0 | 146.0 | 113.0 | 106.0 | 80.0 | 37.8 | 30.0 | 22.8 | 25.9 | 14.1 | 17.3 |
| Other Operating Activities | (2.0) | 44.0 | (5.0) | (14.0) | (20.0) | (1.0) | 33.0 | 14.0 | (27.5) | (23.7) | 5.5 | 5.8 | (29.7) | 17.1 |
| Change in Working Capital | (280.0) | (84.0) | 680.0 | 459.0 | 19.0 | (106.0) | (292.0) | 212.0 | (69.0) | (45.9) | 59.8 | 12.5 | (82.5) | 103.3 |
| Cash From Operations | 2 149.0 | 2 260.0 | 2 942.0 | 1 959.0 | 1 417.0 | 1 254.0 | 970.0 | 860.0 | 475.7 | 431.8 | 397.4 | 335.7 | 161.0 | 378.2 |
| INVESTING CASH FLOW | ||||||||||||||
| Capital Expenditures | (649.0) | (674.0) | (640.0) | (616.0) | (582.0) | (459.0) | (369.0) | (164.0) | (78.4) | (82.7) | (92.3) | (71.3) | (75.7) | (80.2) |
| Other Items | (954.0) | (1 332.0) | (1 463.0) | (180.0) | (608.0) | (351.0) | (821.0) | 1 895.0 | 11.4 | (90.5) | (147.8) | (60.9) | (149.2) | (61.2) |
| Cash From Investing Activities | (1 603.0) | (2 006.0) | (2 103.0) | (796.0) | (1 190.0) | (810.0) | (1 190.0) | 1 731.0 | (67.0) | (173.1) | (240.2) | (132.2) | (224.8) | (141.4) |
| FINANCING CASH FLOW | ||||||||||||||
| Common Stock Repurchased | (992.0) | (1 168.0) | (406.0) | (447.0) | (949.0) | (1 405.0) | (2 620.0) | (1 097.0) | (515.0) | (415.0) | (6.4) | (13.4) | (14.3) | (9.3) |
| Total Debt Repaid | 802.0 | 941.0 | 70.0 | 342.0 | 747.0 | 1 015.0 | 2 511.0 | (1 313.0) | 188.0 | 242.0 | (387.7) | 440.1 | 260.1 | (78.4) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (567.9) | (288.3) | (67.5) |
| Other Financing Activities | (192.0) | (102.0) | (899.0) | (112.0) | (74.0) | (62.0) | 37.0 | 126.0 | 77.8 | 42.7 | (60.0) | (8.9) | (16.8) | 2.0 |
| Cash From Financing Activities | (382.0) | (329.0) | (1 235.0) | (217.0) | (276.0) | (452.0) | (72.0) | (2 284.0) | (249.2) | (130.3) | 71.0 | (146.9) | (59.3) | (153.1) |
| CHANGE IN CASH | ||||||||||||||
| Net Change In Cash | 160.0 | (150.0) | (448.0) | 977.0 | (54.0) | (68.0) | (239.0) | 221.0 | 109.8 | 89.2 | 210.4 | 51.4 | (130.3) | 80.8 |
| FREE CASH FLOW | ||||||||||||||
| Free Cash Flow | 1 500.0 | 1 586.0 | 2 302.0 | 1 343.0 | 835.0 | 795.0 | 601.0 | 696.0 | 397.3 | 349.1 | 305.0 | 264.4 | 85.3 | 297.9 |